2026-09-18T17:11:19Zhttps://scholarsbank.uoregon.edu/server/oai/request

oai:scholarsbank.uoregon.edu:1794/228252025-09-10T20:51:54Zcom_1794_7557com_1794_7555com_1794_7552col_1794_169

Bonaparte, James Porter 2017-10-10T22:50:17Z 2017-10-10T22:50:17Z 2017 https://hdl.handle.net/1794/22825 36 pages. A thesis presented to the Department of Biology and the Clark Honors College of the University of Oregon in partial fulfillment of the requirements for degree of Bachelor of Science, Spring 2017 This thesis explores the possibility of detecting early signs of potentially life threatening melanoma through a simple blood test before the cancer reaches an untreatably fatal stage. There is promising data to support that such an assay is possible to determine whether a patient may have metastatic melanoma. This early detection is possible because the body appears to synthesize antibodies against transient receptor potential melastatin 1 (TRPM1), when under the stress of metastatic melanoma. We can easily synthesize the portion of TRPM1 peptide that the human antibody recognizes, and therefore measure whether or not the patient has these critical antibodies in their blood serum. The presence of these antibodies is a red flag and can hopefully lead to immediate examination from a doctor who may be able to stop the disease from progressing further. This assay can hopefully save many lives. en_US University of Oregon Creative Commons BY-NC-ND 4.0-US Melanoma Skin cancer Immune system TRPM1 Antibodies Blood test Developing a Screening Process for Early Detection of Melanoma Thesis/Dissertationopen.access